XML 20 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash Flow - Operating Activities    
Net Cash Provided by Operating Activities $ 60,941 $ 54,152
Cash Flows — Investing Activities    
Proceeds from sale of real estate 96,674 46,381
Capital contributions to equity investments in real estate (81,989) (3,364)
Return of capital from equity investments in real estate 17,781 9,745
Acquisitions of real estate and direct financing leases (11,393) (28,135)
Value added taxes refunded in connection with acquisition of real estate 5,412 2,492
Changes in investing restricted cash 5,229 (27,394)
Payment of deferred acquisition fees to an affiliate (1,245) (1,363)
Capital expenditures on owned real estate (663) (3,161)
Other investing activities, net 489 108
Funding for build-to-suit projects (236) (498)
Value added taxes paid in connection with acquisition of real estate 0 (5)
Net Cash Provided by (Used in) Investing Activities 30,059 (5,194)
Cash Flows — Financing Activities    
Scheduled payments and prepayments of mortgage principal (243,136) (21,767)
Proceeds from mortgage financing 104,287 69,188
Distributions paid (55,830) (54,775)
Proceeds from Senior Credit Facility 33,878 25,693
Proceeds from issuance of shares, net of issuance costs 25,761 26,019
Repurchase of shares (11,314) (9,095)
Distributions to noncontrolling interests (9,944) (9,620)
Other financing activities, net (550) 0
Payment of financing costs and mortgage deposits, net of deposits refunded (45) (1,079)
Changes in financing restricted cash (14) (455)
Repayments of Senior Credit Facility 0 (113,854)
Contributions from noncontrolling interests 0 5
Net Cash Used in Financing Activities (156,907) (89,740)
Change in Cash and Cash Equivalents During the Period    
Effect of exchange rate changes on cash 1,323 3,061
Net decrease in cash and cash equivalents (64,584) (37,721)
Cash and cash equivalents, beginning of period 273,635 152,889
Cash and cash equivalents, end of period $ 209,051 $ 115,168